Risk of HCV infection in haemophiliacs treated with a dry-heated factor VIII concentrate.
Kolho
E
E
Ebeling
F
F
Rasi
V
V
D005169:Factor VIII / Q000009:adverse effects*; D005500:Follow-Up Studies; D006467:Hemophilia A / Q000628:therapy*; D006526:Hepatitis C / Q000635:transmission*; D006358:Hot Temperature; D006801:Humans; D012307:Risk Factors; D013048:Specimen Handling / Q000379:methods
D005169:Factor VIII